How Dental Practices Can Talk to Patients About Peptides Without Making Claims
Scripts and boundaries for the front desk, hygienists, and the dentist when a patient asks about BPC-157 after an extraction. Point to the evidence, never the product.
PeptIQ Team
Peptide Research & Education
PeptIQ app
Track your peptide protocols in PeptIQ
Log injections, vial supply, and reminders. Use peptiq.io calculators when you need math on the web.
Under 25? Talk to a licensed clinician and get baseline labs before starting anything. Why we say this · Labs checklist
The problem is not the question, it is the fourth different answer
A patient asks the front desk whether they should take BPC-157 after their extraction. The front desk says "I think some people do." The hygienist says "I've heard good things." The assistant says "That stuff isn't legal." The dentist, last to hear it, says "Where did you get that?" Four answers, two of them claims, none of them cited.
Dental practices do not need a peptide policy so much as a shared, sourced reference and three short scripts. This guide gives you both. The reference is the dental evidence guide; the scripts are below.
Educational only, not legal advice. PeptIQ.io does not sell, source, or dispense peptides.
Three rules that keep everyone safe
Say what was studied, never what it does. "There is one rat study of gum disease" is a fact. "It helps gums heal" is a claim. The difference is the whole game.
Point to the evidence, not a product or a vendor. A practice that names a seller, a brand, or a "guy" has made a recommendation whether it meant to or not.
Route anything compounded to the prescriber-and-pharmacy lane. Whether a peptide can be compounded is an FDA and state-board question. Your office does not supply it, so your office does not answer it beyond "that's a prescriber decision."
Tier 1: the front desk
The front desk should never say yes, no, or a brand. One sentence, every time:
> "That's a question for the doctor. I'll note it so it's covered at your visit."
Then actually note it. The question going on the chart is what turns a hallway conversation into a documented one.
If the patient pushes ("but is it legal?"), the front desk has one more line:
> "The doctor can show you what has actually been studied and what the FDA has said. I don't want to guess."
Tier 2: hygienist or assistant
Clinical staff can go one level deeper, still without claims:
> "Some of these have animal studies, a couple have small human studies, and the ones that are FDA-approved for dental use are different products from the ones people buy online. The doctor can walk you through what's been studied for your situation."
Useful facts a hygienist can state because they are on the record:
Enamel matrix derivative and rhPDGF-BB are FDA-approved periodontal devices with decades of trials. These are things a periodontist uses in surgery, not injectables a patient buys.
For BPC-157, the dental literature is one rat periodontitis study, one rat oral-injury model, and three uncontrolled human cases whose authors say causality cannot be established.
For TB-500, the dental studies used full-length thymosin beta-4, not the fragment sold online, and they are animal or cell-culture studies.
For GHK-Cu, we found no dental or oral study at all.
Each of those is cited on the evidence guide, which the hygienist can open on the operatory screen.
Tier 3: the dentist
The dentist gives the full, cited answer and closes the loop on supply:
> "Here is what has been studied, in whom, and what it showed. For the thing you're asking about, that means [one rat study / three case reports / no study]. Anything compounded is a decision between a prescriber and a pharmacy that will put its authority in writing, and it's not something this office supplies. If you want to pursue it, that's the conversation to have, and I'm happy to send you what has actually been published."
Then document three things: the question, what you showed the patient, and that no product was recommended or supplied.
Phrases to retire
Instead of
Say
"It helps healing."
"It was studied in a rat model of healing. There's no human trial."
"It's totally safe."
"FDA has said it has little or no safety information for the proposed routes. That's the record."
"It's illegal."
"It isn't FDA-approved, and whether a pharmacy can compound it is a question for the prescriber and the pharmacy."
"Everyone's using it."
"Plenty of people ask. Here is what's actually been published."
"Try this site."
"I don't recommend sellers. I can show you the studies."
When the patient already bought it
This happens. The conversation changes from "should I" to "I am," and the office's job is still not to endorse or supply. Reasonable moves:
Record it in the medical history like any other substance the patient reports using.
Ask where it came from, without judgment, so the prescriber knows whether a licensed pharmacy or a research-chemical storefront is involved. FDA warning letters treat human-use marketing of "research use only" peptides as unapproved drug distribution.
Share the published record and let the patient make their own decision with their prescriber.
Where the approved biologics fit
Patients sometimes conflate the injectable they read about with the biologic their periodontist used. That is a useful teaching moment: "The material we used in your pocket surgery is enamel matrix derivative. It has an FDA approval from 1996 and about sixty-seven randomized trials behind it. That is a very different thing from a peptide bought online." The periodontal regeneration guide gives the whole list.
Making the reference stick
The reason four staff give four answers is that the evidence lives in the dentist's head. Put it where staff and patients can both read it:
Hand patients the PDF version rather than a verbal summary; the gate on that page emails it.
If your practice uses the PeptIQ.io provider console, the same evidence and FDA status appear inside the patient app with the sources attached, so the patient's own phone gives the cited answer when they ask again at 10 p.m.
See the provider console
PeptIQ.io for providers is a provider console plus the PeptIQ patient app: protocol templates with phases, patient dose and vial logging, an adherence roster with nudges, staff roles across locations, vial flags, Provider AI, and a revenue forecast from active protocols. It is not an EHR and it does not sell peptides.
A: PeptIQ.io does not give legal advice. Compounded peptides are a prescriber-and-pharmacy pathway, and FDA has written about most of the ones patients ask for. Read the authority behind each amber light and talk to counsel before anything appears on a menu.
Q: Is it a "claim" to say a peptide was studied in rats?
A: Stating what a published study did and reported is description, not a claim about the product. Saying or implying the product will do that for the patient is a claim. Keep the sentence about the study.
Q: What should we do if a vendor offers to "educate" our staff?
A: Ask for the PubMed IDs and the FDA page for every statement in the deck, then check them. The evidence guide shows what a checked list looks like.
This article is educational content from PeptIQ for clinic operators. It is not medical, legal, or regulatory advice. Prescribing, compounding, and consent decisions belong with licensed clinicians, pharmacists, and your counsel. PeptIQ does not sell, source, or dispense peptides.
